CSLLY:OTCMKTS
CSL ADR
$35.39
arrow_upward
+1.11%(+0.39) 1D
Oct 30, 3:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSLLY...
Open
$35.48
High
$35.48
Low
$35.22
Mkt. cap
96.33B
Avg. vol.
60.78K
Volume
26.93K
52-wk high
$35.64
52-wk low
$16.01
Beta
0.53
Shares outstanding
1.92B
No. of employees
29K
Open
$35.48
High
$35.48
Low
$35.22
Mkt. cap
96.33B
Avg. vol.
60.78K
Volume
26.93K
52-wk high
$35.64
52-wk low
$16.01
Beta
0.53
Shares outstanding
1.92B
No. of employees
29K
News stories
From web sources and news partners
The Motley Fool Australia
·
14 hours ago
Are CSL shares a buy, hold, or sell at their 52-week high?
Stockhead
·
2 days ago
Scott Power: ASX healthcare stocks up as economic headwinds cast spooky shadow
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com